Found: 5
Select item for more details and to access through your institution.
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 94, doi. 10.1111/dom.13042
- By:
- Publication type:
- Article
Efficacy of the Roux-en-Y Gastric Bypass Compared to Medically Managed Controls in Meeting the American Diabetes Association Composite End Point Goals for Management of Type 2 Diabetes Mellitus.
- Published in:
- Obesity Surgery, 2012, v. 22, n. 3, p. 367, doi. 10.1007/s11695-011-0494-y
- By:
- Publication type:
- Article
Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 27, doi. 10.1002/cpdd.181
- By:
- Publication type:
- Article
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 1, p. e2033457, doi. 10.1001/jamanetworkopen.2020.33457
- By:
- Publication type:
- Article
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2020836, doi. 10.1001/jamanetworkopen.2020.20836
- By:
- Publication type:
- Article